Immunophotonics crunchbase

Author: rwfm

August undefined, 2024

WitrynaCompany Type For Profit. Contact Email [email protected]. China Immunotech is a small molecule innovative drug R&D company developing immune cell therapy technologies and products. Including CAR-T and TCR-T cell therapy with independent intellectual property rights. It was founded in March 2024 by famous … WitrynaImmunoPhotonics raised $1800000 on 2014-09-03 in Series A. Start Free Trial . Chrome Extension

Tomas Hode - Co-Founder & Chief Information Off.. - AACR

WitrynaImmunophotonics is a privately owned clinical-stage biotech company that is pioneering the burgeoning field of Interventional Immuno-OncologyTM through the development of novel treatments for solid-tumor cancers. IP-001, the first asset from the company’s intellectual property platform, has the potential to transform a routine tumor ablation … WitrynaImmunoPhotonics. Biotechnology. Health Care. Life Science. $21M: 06 Apr 2024: iSELECT FUND. Columbia, Missouri, United States: By posting comments on our website you confirm and acknowledge that: 1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the … assassin meaning

ImmunoPhotonics - Crunchbase Company Profile & Funding

Witryna6 kwi 2024 · ImmunoPhotonics. Announced Date Apr 6, 2024. Funding Type Series B. Funding Stage Early Stage Venture. Money Raised $21.4M. WitrynaNumber of Current Board & Advisor Roles 1. Number of Founded Organizations 1. Primary Job Title CEO & Co-Founder. Primary Organization. ImmunoPhotonics. … Witryna27 maj 2011 · ImmunoPhotonics raised $100123 on 2011-05-27 in Pre Seed Round. Unlock even more features with Crunchbase Pro assassin martin luther king

Immunophotonics crunchbase

Witryna18 mar 2024 · Co-Founder & Chief Information Officer & President, At Immunophotonics, Inc at AACR . Tomas Hode, Ph.D., who received his Ph.D. in 2005, is a co-founder of Immmunophotonics, and has more than 10 years experience in the medical laser device industry. Dr. Hode has been a board member of the Missouri … WitrynaImmunoPhotonics raised $50000 on 2013-05-14 in Grant. Start Free Trial . Chrome Extension

Did you know?

Witryna9 sie 2024 · ImmunoPhotonics. Crunchbase Website Twitter Facebook Linkedin. Minimally invasive therapeutic cancer vaccine for the treatment of metastatic solid tumors. EyePromise. Crunchbase Website Twitter Facebook Linkedin. EyePromise manufactures and sells zeaxanthin dietary supplements for those at risk of age … WitrynaOperating Status Active. Last Funding Type Post-IPO Debt. Legal Name Rockley Photonics Ltd. Stock Symbol NYSE:RKLY. Company Type For Profit. Contact Email [email protected]. Phone Number +1 626-304-9960. Rockley is developing a comprehensive range of photonic integrated circuits and associated …

WitrynaImmunophotonics is a privately owned clinical stage biotech that has discovered a novel and simple approach to achieve patient-specific anticancer immunity. The … Witryna21 cze 2024 · Patients with laser ablation-accessible solid tumors are treated by thermal ablation followed immediately by an intratumoral injection of IP-001 (1 % N-dihydro-galacto-chitosan, Immunophotonics Inc.) for injection). IP-001 is intended to trigger a tumor-specific systemic immune response when exposed to tumor antigens liberated …

WitrynaFounded Date 2024. Founders Ben Rubovitch, Kobi Hasharoni, Yoel Chetrit. Operating Status Active. Last Funding Type Series B. Legal Name DustPhotonics Inc. Company Type For Profit. Contact Email [email protected]. DustPhotonics develops and manufactures pluggable optical modules and solutions for data center, enterprise … WitrynaFounded Date Dec 1, 2016. Founders Russ Kanjorski, Russell Kanjorski, Scott Burroughs. Operating Status Active. Last Funding Type Series A. Also Known As Sense. Legal Name Sense Photonics, Inc. Company Type For Profit. Contact Email [email protected]. Phone Number 919-248-1470.

Witryna26 sty 2015 · ImmunoPhotonics raised $600000 on 2015-01-26 in Series A. Cultivation Capital Cultivation Capital is a venture capital firm managing funds focused on …

WitrynaPrisma Photonics keeps critical large-scale infrastructures running by providing optical fiber sensing solutions. The company was founded in 2024 by a team of entrepreneurs with experience in lasers, optical fiber, algorithms, and machine learning. lamellen akustikWitrynaKi3 Photonics Technologies comprises experts in the generation and processing of quantum photonic signals. The company’s mission is to create innovative products and solutions in order to shape the future of a quantum enabled internet. lamella ukraineWitrynaCenter at Johns Hopkins University Medical Center on the biology of whole cell tumor vaccines. Dr. Lam has taken the position of Immunoassay Scientist at the The Center … lamellen assenWitrynaImmunophotonics, Inc. 479 followers on LinkedIn. Interventional Immuno-Oncology Immunophotonics is a privately owned clinical stage biotech that has discovered a novel and simple approach to achieve patient-specific anticancer immunity. The company is currently developing its first asset, the immune-modulating proprietary carbohydrate … lamellen aluminium jaloezieënWitrynaFounded Date 1983. Operating Status Active. Last Funding Type Post-IPO Equity. Also Known As IPA. Stock Symbol NASDAQ:IPA. Company Type For Profit. Contact Email … lamellen autoWitrynaFounded Date 1987. Operating Status Active. Legal Name Immuno-Biological Laboratories, Inc. Company Type For Profit. Contact Email [email protected]. Phone Number +1 888 523 1246. IBL - America's research and clinical markets include but are not limited to autoimmunity, endocrinology, infectious disease, oncology and … lamellen automatisch makenWitrynaCB Rank (Person) 549,025. Primary Job Title Co-Founder. Primary Organization. ImmunoPhotonics. Gender Male. Dr. Hode has worked in the photomedicine and … lamellen aan muur